These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21784533)

  • 1. The influence of personality factors on paroxetine response time in patients with major depression.
    Kaneda A; Yasui-Furukori N; Nakagami T; Sato Y; Kaneko S
    J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder.
    Tomita T; Ishioka M; Kaneda A; Sugawara N; Nakagami T; Nakamura K; Yasui-Furukori N
    J Affect Disord; 2014 Aug; 165():109-13. PubMed ID: 24882186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
    Tomita T; Kaneda A; Nakagami T; Kaneko S; Yasui-Furukori N
    Hum Psychopharmacol; 2015 Sep; 30(5):334-40. PubMed ID: 25845342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study.
    Tomita T; Yasui-Furukori N; Kaneda A; Ishioka M; Sugawara N; Nakagami T; Nakamura K
    BMC Psychiatry; 2016 Aug; 16():290. PubMed ID: 27520460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB; Cloninger CR; Watson JP; Isaac MT
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personality traits as risk factors for treatment-resistant depression.
    Takahashi M; Shirayama Y; Muneoka K; Suzuki M; Sato K; Hashimoto K
    PLoS One; 2013; 8(5):e63756. PubMed ID: 23717477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the state dependency of the Temperament and Character Inventory dimensions in patients with major depression: a methodological contribution.
    Hirano S; Sato T; Narita T; Kusunoki K; Ozaki N; Kimura S; Takahashi T; Sakado K; Uehara T
    J Affect Disord; 2002 May; 69(1-3):31-8. PubMed ID: 12103449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of personality on the association between paroxetine plasma concentration and response.
    Tomita T; Yasui-Furukori N; Nakagami T; Tsuchimine S; Ishioka M; Kaneda A; Nakamura K
    Neuropsychiatr Dis Treat; 2018; 14():3299-3306. PubMed ID: 30568452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients.
    Kampman O; Poutanen O; Illi A; Setälä-Soikkeli E; Viikki M; Nuolivirta T; Leinonen E
    Eur Psychiatry; 2012 May; 27(4):245-9. PubMed ID: 20933372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperament and character influence on depression treatment outcome.
    Balestri M; Porcelli S; Souery D; Kasper S; Dikeos D; Ferentinos P; Papadimitriou GN; Rujescu D; Martinotti G; Di Nicola M; Janiri L; Caletti E; Mandolini GM; Pigoni A; Paoli RA; Lazzaretti M; Brambilla P; Sala M; Abbiati V; Bellani M; Perlini C; Rossetti MG; Piccin S; Bonivento C; Fabbro D; Damante G; Ferrari C; Rossi R; Pedrini L; Benedetti F; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2019 Jun; 252():464-474. PubMed ID: 31005789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
    Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
    J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.
    Aberg-Wistedt A; Agren H; Ekselius L; Bengtsson F; Akerblad AC
    J Clin Psychopharmacol; 2000 Dec; 20(6):645-52. PubMed ID: 11106136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between sunshine duration and paroxetine response time in patients with major depressive disorder.
    Tomita T; Yasui-Furukori N; Nakagami T; Kaneda A; Kaneko S
    J Affect Disord; 2012 Feb; 136(3):1067-71. PubMed ID: 22153922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personality change during depression treatment: a placebo-controlled trial.
    Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
    Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality changes during antidepressant treatment.
    Hruby R; Nosalova G; Ondrejka I; Preiss M
    Psychiatr Danub; 2009 Mar; 21(1):25-32. PubMed ID: 19270618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
    Boz C; Gazioglu S; Altunayoglu V; Hocaoglu C
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):534-42. PubMed ID: 17875033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERT and NET polymorphisms, temperament and antidepressant response.
    Andre K; Kampman O; Illi A; Viikki M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Haraldsson S; Koivisto PA; Leinonen E
    Nord J Psychiatry; 2015; 69(7):531-8. PubMed ID: 25739526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM; Gao KR; Yu H; Shen YF; Li HF
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
    Kertzman S; Vainder M; Reznik I; Gotzlav Y; Weizman A; Kotler M; Iancu I
    Int Clin Psychopharmacol; 2012 May; 27(3):134-41. PubMed ID: 22415223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.